OBJECTIVES To evaluate the effect on endocrine and metabolic parameters of a new combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP). STUDY DESIGN Randomized, open-label, controlled, three-arm, parallel study. Healthy subjects received either E4 15 mg/DRSP 3 mg (E4/…